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Abstract: Acetaminophen, a pain-reliever, is one of the most widely used medications in 
the world. Acetaminophen with normal dosage is considered a nontoxic drug for therapeutic 
applications, but when taken at overdose levels it produces liver damage in human and various 
animal species. By a high energy mechanically activated method, we produced acetaminophen 
in a nanometer crystalline size (24 nm). Forty-eight hours after injection of crystalline particles 
with normal and reduced size of our drug, the effect of liver toxicity was compared by determi-
nation of liver transferase enzymes such as alkaline phosphatase, aspartate aminotransferase, 
and alanine aminotransferase (ALT). These enzymes were examined by routine colorimetric 
methods using commercial kits and pathologic investigations. Statistical analysis and pathological 
figures indicated that ALT delivery and toxicity in reduced size acetaminophen was significantly 
reduced when compared with normal size acetaminophen. Pathology figures exhibited reduced 
necrosis effects, especially the confluent necrosis, in the central part of the lobule in the reduced 
size acetaminophen samples when compared with the normal samples.
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Introduction
Nanotechnology consists of the study, control, and construction of nanosized materi-
als (10-9 m).1,2 The generation of nanoparticle drugs has created new perspectives in 
pharmacology. However it is essential to discover the properties of nanoparticles for 
the successful development of nanoparticle drugs. High pressure homogenization 
and supercritical fluid processing are technologies that are used today or are being 
developed for the generation of nanoparticles.3,4 Drug synthesis at the nanoscale com-
menced when interesting nanomaterial properties were discovered by their presence 
in particular areas of the human body. The employment of the mill was one of the first 
ideas for the transfer of the drug to the nanoscale.3–5 One of the methods for preparation 
of micro- and nanoparticles is mechanical activation. The actual process of mechani-
cal alloying starts with mixing of the powders in the right proportion and loading the 
powder mix into the mill along with the grinding medium (generally steel balls). This 
mix is then milled for the desired length of time until a steady state is reached when 
the composition of every powder particle is proportional to the elements in the starting 
powder mix. Thus the important components of the mechanical alloying process are 
the raw materials, the mill, and the process variables. Particle size reduction, which 
increases the contact surface between particles, is the direct consequence of milling. 
When the energy of the system increases, mullitization temperatures decrease.6International Journal of Nanomedicine 2010:5 198
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  sensitivity (PM-4800; Mettler, Zürich, Switzerland), a precise 
balance scale with 0.0001 g (AE-200; Mettler), surgical blade, 
centrifuge, microplates of 10, 20, 50, and 100 µm (Eppendorf, 
Hamburg, Germany) with a replaceable and disposable usable 
syringe, 5 mL pipettes, volumetric flask, 10 mL plastic labo-
ratory tube, 500 µL and 100 µL samplers, acetaminophen 
powder with an average size of 1 µm (Chimidarou Co, Tehran, 
Iran), formalin solution (10% w/w), enzymatic kits (Emapol, 
Gdan ´sk, Poland), distilled water, ethanol, xyelen, dimethyl 
sulfoxide (DMSO) 20% w/w, and paraffin.
Methods
The standard acetaminophen powder with an average size 
of 1 µm and 1:15 weight ratio (ball to powder) were poured 
into the milling jar. The jar was mechanically activated 
for a short period of time. The sample was converted into 
a crystalline particle size of 24 nm with the mechanically-
activated method.
The rats were kept for 24 hours without any food before 
the injection. This drug powder with an overdose of two 
different sizes (800 mg kgG b.wt) with a DMSO control 
sample was intravenously injected into three groups of male 
rats (n = 7). Tissue samples were taken from their liver and 
placed into formalin solution. Small parts of this tissue were 
removed from the formalin solution and placed into the alco-
hol solution with an increasing percentage of solubility (70%, 
80%, 90%, and 100% w/w). The samples were dehydrated. 
The tissue was placed into a xyelen solution after extracting 
all the alcohol used in dehydration step. Finally, the tissue 
became transparent. This procedure was performed automati-
cally with tissue processor instrumentation. Afterwards, the 
samples were soaked into melting paraffin and the paraffin 
diffused completely into the tissue samples to form an inter-
nal mold. To generate external molds, we also used melting 
paraffin. After pouring paraffin on the tissue samples, they 
were placed into two L-shaped aluminum molds and kept in 
a cold environment to solidify the mold. The samples were 
cut into pieces of 3–5 µm.
The tissue samples were stained with hematoxylin and 
eosin to prepare them for microscopic examination. For the 
enzymatic investigation, drug powder with two different sized 
overdoses and a DMSO controller was intravenously injected 
in three groups of male rats. The rats were kept for 24 hours 
without any food before the injection. Blood samples were 
taken from all injected rats and then centrifuged. With the 
help of the alkaline phosphatase (ALP), ALT, aspartate 
aminotransferase (AST) enzyme recognition kits and the 
relative spectrometer functions, the relative numbers for the 
Mechanical activation has become a phenomenon of 
general significance in pharmaceutics. Hüttenrauch and 
colleagues described the extent of activation induced by 
relevant processes7 and Haüsler studied the influence of 
mechanical activation on the physical stability of salbutamol 
sulfate.8
Acetaminophen (C8H9NO2) is a crystalline white powder 
with a bitter taste, is odorless, and has a molecular weight 
of 151.16.9,10 About 90% of acetaminophen reacts with 
30% sulphate and 60% glucuronide in the liver. These two 
metabolic pathways can be saturated. Some unmetabolized 
acetaminophen will be excreted through the kidney. Only a 
small amount of drug (maximum 15% to 20%) is changed 
to active metabolites through the mixed function of the kid-
ney oxidase. In the presence of sufficient glutathione, this 
intermediate material is changed to mercapturic acid and 
cysteine and this function causes detoxification. A single 
dose of 800 mg kgG b.wt caused a severe hepatocellular 
injury as indicated by a massive increase in serum alanine 
aminotransferase (ALT) activity and decreased plasma level 
of the parent acetaminophen.
Acetaminophen has poor solubility in water. It is well 
known that bioavailability of drugs with low solubility is 
often intrinsically related to drug particle size. The dissolution 
rate is reported to increase by one or more orders by reducing 
the magnitude of the drug particle and hence can lead to faster 
absorption rates.10 The main factor for this toxicity can be 
attributed to the toxic metabolite N-acetyl-p-benzo-quinone 
imine (NAPQI) produced in the liver by changing a small 
percentage (about 5%–10%) of the acetaminophen dose in the 
P450 cytochrome.11,12 In this condition, glutathione rapidly 
changes this toxic material to cysteine and mercapturate. 
Mercapturate is a stable metabolite that gradually leaves 
the body. The glutathione sources reduce progressively to 
its critical limit (30% of the abnormal source). As a conse-
quence, mercapturate will not be able to neutralize NAPQI 
and this material will form a covalent bond with the cells, 
macromolecules, and the nucleus proteins of the liver, lead-
ing to necrosis of the central lobules.13,14 In this study, the 
size of the acetaminophen particles was reduced with the 
use of a mechanically activated dry mill and the effect of 
the reduced size on the liver toxicity was investigated with 
an overdose injection .
Materials and methods
Materials and instruments
Ball mill, spectrophotometer (NAVA speed; Nava Vadaj, 
Ahmedabad, India), a digital balance scale with 0.01% International Journal of Nanomedicine 2010:5 199
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enzymes were studied and analyzed. Student’s t-test was used 
to estimate the differences.
Results
The pathological investigation on the liver tissue for the 
normal, control (DMSO), and reduced size acetaminophen 
samples were conducted. The corresponding results are 
  presented in Tables 1, 2, and 3. 1L shows various liver tissue 
samples injected with normal acetaminophen samples. 2L is 
related to the control samples, and 3L is associated with the 
liver samples which have been injected with the reduced size 
acetaminophen samples.
Figures 1 and 2 display the pathological images of two 
liver tissue samples: i) the reduced size acetaminophen samples 
(24 nm); and ii) the normal size samples. Figure 1 is related 
to the reduced size acetaminophen samples (3L). In this liver 
sample, spotty necrosis around the central vein can be clearly 
identified. Figure 2 shows the normal size acetaminophen 
samples. In addition to the spotty necrosis, the confluent 
necrosis can also be observed around the central vein. Figure 2 
shows the damage to the nucleuses and the cytoplasm.
In the enzymatic investigations, the AST, ALP, ALP 
enzyme activities and statistical estimations was estimated 
and evaluated with statistical significance of P  0.05. These 
results are listed in Table 4 and Figure 3.
Conclusion
In this study, a new method was introduced for determin-
ing the size reduction effect of acetaminophen particles 
from the average size of 1 µm to 24 nm. This reduction 
was achieved with the use of the mechanical activation 
and the enzyme effects on the liver toxicity of the rats 
Table 3 The results of the injection of the reduced size acetaminophen 
samples into the liver
Reduced size  
acetaminophen
Pathological results  
of the liver tissue
3L Infiltration of the lymphocyte in the 
port, piece meal necrosis in the central 
place, spotty necrosis
A
B
Figure 1 The figures of the liver tissue injected with the reduced size acetaminophen, 
(A) with high resolution, and (B) with low resolution.
Table 1 The results of the injection of the normal acetaminophen 
samples into the liver
Normal  
acetaminophen
Pathological results  
of the liver tissue
1L 
 
Infiltration of lymphocyte in the port, 
piecemeal necrosis around the confluent 
necrosis in the central part
Table 2 The results of the injection of the control acetaminophen 
samples into the liver
Control Pathological results of the liver 
tissue
2L Slow infiltration of the lymphocyte in 
the port
were compared. The results of the tissue samples in 
  pathological investigations after the injection showed 
less complete spotty necrosis, especially in the confluent 
necrosis in the central lobule portion, for the reduced size 
acetaminophen samples when compared with the normal 
samples. We can infer that reduced size acetaminophen 
has lower effects on liver toxicity when compared with 
the normal one.International Journal of Nanomedicine 2010:5 200
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Table 4 The given statistical results, estimated from the difference between the control, the normal, and the reduced size acetaminophen 
in three enzymes
Dependent 
  variable
(1) Drug  (J) Drug  Mean difference (I–J)  Std. error  Sig. 
GOT acetaminophen nano  
vehicle
-11.052500  
51.720357*
8.6227438  
9.1841483
0.421 
0 000
nano acetaminophen  
vehicle
11.052500  
62.772857*
8.6227438 
8.9428715
0.421  
0.000
vehicle acetaminophen  
nano
-51.720357* 
-62.772857*
9.1841483  
8.9428715
0.000 
0.000
GPT acetaminophen nano  
vehicle
13.598611* 
27.627500*
4.8854754  
5.2035560
0.029  
0.000
nano acetaminophen  
vehicle
-13.598611*  
14.028889*
4.8854754  
5.0668534
0.029  
0.030
vehicle acetaminophen  
nano
-27.627500* 
-14.028889*
5.2035560  
5,0668534
0.000  
0.030
ALP acetaminophen nano  
vehicle
–22.217917  
9.204464
13.586678  
14.471271
0.253  
0.802
nano acetaminophen  
vehicle
22.217917  
31.422381
13.586678  
14.091096
0.253  
0.089
  vehicle acetaminophen  
nano
-9.204464  
-31.422381
14.471271 
14.091096
0.802  
0.089
Abbreviations: ALP, alkaline phosphatase;   ALT, alanine aminotransferase;   AST, aspartate aminotransferase.
A B
Figure 2 Images of the liver tissue injected with the normal size acetaminophen, (A) with high resolution, and (B) with low resolution.
The tissue samples in enzymatic investigations 
illustrated that the results in Table 4 were related to the 
intravenous injection of the powders and the enzymatic 
activation exhibited no change in the quantity of ALP 
and AST with the reduced and normal size of the injected 
drug. On the other hand, the activation related to the 
quantity ALT demonstrated a reduction for the reduced 
size powders. The statistical investigation of the Student’s 
t-test made it clear that the intravenous injection of the 
reduced size drug samples changed the enzymatic ALT 
quantity. This observation was confirmed by the results 
displayed in Table 4 (P  0.05) and revealed the ALT 
specificity for the liver enzyme. This may be because 
these enzymes are not only found in the liver, but also in 
different places in the body. The toxicity of the injected 
samples with the reduced size was (in pathological 
figures and ALT enzyme) lower than that in the normal 
sized samples.International Journal of Nanomedicine 2010:5
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metabolism, absorption effects of reducing the activated 
particle size on liver-conjugated systems like glucuronide, 
sulfate increases, and toxic metabolite production will be 
reduced.
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Figure 3 The amount of the delivered enzymes related to the blood circulation for 
different enzymes and the difference between three types of injection materials.
Abbreviations: ALP, alkaline phosphatase;   ALT, alanine aminotransferase;   
  AST, aspartate aminotransferase.
Nevertheless, further investigation should be carried out 
in this field. For instance using various animals with a longer 
follow-up time after drug injection. Kinetic effects may mean 
increasing the connection among the reduced size acetamino-
phen particles and plasma proteins for slower drug delivery 
to the liver system. The appropriate time for eliminating toxic 